Jump to content

Joel Habener

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Eight96Four (talk | contribs) at 04:31, 2 May 2021 (#suggestededit-add 1.0). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Joel Habener is a Professor of Medicine at Harvard Medical School who has done fundamental studies on elucidating the role of incretin hormones such as Glucagon-like peptide-1 (GLP-1) and Glucagon-like peptide-2 (GLP-2). For his discoveries, he was awarded the 2020 Warren Alpert Foundation Prize along with Daniel Drucker and Jens Juul Holst.[1] He was elected to the National Academy of Sciences in 2020.[2] In 2021 he was awarded the Canada Gairdner International Award.[3]

References

  1. ^ "Prize Recipients | Warren Alpert Foundation Prize". warrenalpert.org.
  2. ^ "2020 NAS Election". www.nasonline.org.
  3. ^ Canada Gairdner International Award 2021


Flag of United StatesScientist icon

This biographical article related to a physician in the United States is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Joel_Habener&oldid=1020970761"